» Articles » PMID: 33224088

Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19-A Case Series

Abstract

The affection of both the peripheral (PNS) and central nervous system (CNS) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been assumed to play a direct role in the respiratory failure of patients with Corona virus disease 2019 (COVID-19) through affection of medullary cardiorespiratory centers resulting in neurological complications and sequelae. We used a multimodal electrophysiological approach combined with neuropsychological investigations to study functional alteration of both the PNS and CNS in four patients with severe COVID-19. We found electrophysiological evidence for affection of both the PNS and CNS, and particularly affection of brain stem function. Furthermore, our neuropsychological investigations provide evidence of marked impairment of cognition independent of delirium, and outlasting the duration of acute infection with SARS-CoV-2. This case series provides first direct electrophysiological evidence for functional brain stem involvement in COVID-19 patients without evident morphological changes supporting the notion of the brain stem contributing to respiratory failure and thus promoting severe courses of the disease. Moreover, sustained neuropsychological sequelae in these patients may be of particular psychosocial and possibly also economic relevance for society.

Citing Articles

Neurocognitive and Neuropsychiatric Sequelae in Long COVID-19 Infection.

Almeria M, Cejudo J, Deus J, Krupinski J Brain Sci. 2024; 14(6).

PMID: 38928604 PMC: 11202095. DOI: 10.3390/brainsci14060604.


Investigation of Neuropsychological Dysfunction Among Recovered Nurses: The COVID-19.

Salemi M, Alipour A Cureus. 2024; 16(4):e58929.

PMID: 38800204 PMC: 11123473. DOI: 10.7759/cureus.58929.


Neurological complications after COVID-19: A narrative review.

Molaverdi G, Kamal Z, Safavi M, Shafiee A, Mozhgani S, Ghobadi M eNeurologicalSci. 2023; 33:100485.

PMID: 38077923 PMC: 10700397. DOI: 10.1016/j.ensci.2023.100485.


Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessments.

Balloff C, Bandlow C, Bernhard M, Brandenburger T, Bludau P, Elben S Sci Rep. 2023; 13(1):19619.

PMID: 37949882 PMC: 10638293. DOI: 10.1038/s41598-023-46124-w.


Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis.

Sobrino-Relano S, Balboa-Bandeira Y, Pena J, Ibarretxe-Bilbao N, Zubiaurre-Elorza L, Ojeda N Sci Rep. 2023; 13(1):10309.

PMID: 37365191 PMC: 10293265. DOI: 10.1038/s41598-023-37420-6.


References
1.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

2.
Ogier M, Andeol G, Sagui E, Bo G . How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immun Health. 2020; 5:100081. PMC: 7227537. DOI: 10.1016/j.bbih.2020.100081. View

3.
Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D . COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5). PMC: 7286661. DOI: 10.1212/NXI.0000000000000789. View

4.
Zhao H, Shen D, Zhou H, Liu J, Chen S . Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020; 19(5):383-384. PMC: 7176927. DOI: 10.1016/S1474-4422(20)30109-5. View

5.
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View